Investors

Investors

Investor science conference call ACC 2015

A replay is now available for the presentation of data by the PEGASUS-TIMI 54 trial’s primary investigator Dr. Marc Sabatine to investors and analysts which was followed by a clinical and business status update.

Download presentation (PDF 6806kb)

Replay details

The replay will be available until 7pm GMT on 30 March using the following numbers:

UK freephone: 0800 953 1533
US freephone: 866 247 4222
International: +44 (0) 1452 550000
Conference code: 89630065


Latest information

AstraZeneca refines its financial reporting in line with evolving business model

6 March 2015

AstraZeneca today announces an update to the presentation of its Statement of Comprehensive Income, which will see revenue from externalisation becoming more visible to enhance transparency for investors.

 Download further infomation (PDF 166kb)


AstraZeneca appoints Citibank, N.A. as depositary bank for its U.S. American Depositary Receipt (ADR) Programme

6 February 2015

Download further information (PDF 27kb)

Latest downloads

Investor Relations presentation - March 2015

5 March 2015

Fourth quarter and full year results 2014

5 February 2015

33rd J.P. Morgan Healthcare Conference, San Francisco

14 January 2015

Accounting for the US Branded Pharmaceutical Fee

7 January 2015

AstraZeneca Investor Day

18 November 2014

Third quarter and nine months results 2014

6 November 2014